Press Releases

2010-08-10	CADTH releases its first-ever Biologics class review in Canada HUMIRA® (adalimumab) shown to be most cost-effective anti-TNF
2010-08-04	Global Experts Offer Recommendations to Help Parents Manage “Picky Eaters”
2010-03-01	Abbott Supports McGill University Nurse Practitioner Programs
2009-09-28	Abbott to Acquire Solvay Pharmaceuticals Business
2009-07-24	Health Canada Approves Abbott’s XIENCE V® Drug Eluting Stent
2009-04-27	Interim Results of Abbott’s PROGRESS Study Show Rapid Viral Decline in Dual-Therapy Regimen of Kaletra (lopinavir/ritonavir) and Raltegravir
2009-04-15	Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
2009-02-20	Abbott Announces 11 Percent Increase in Quarterly Dividend
2009-02-18	Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor
2009-01-21	Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings
2009-01-15	Abbott Nutrition Statement on Melamine and Cyanuric Acid
2008-12-12	Abbott Declares 340th Consecutive Quarterly Dividend
2008-09-26	Standby Statement for Medical Nutrition products
2008-09-18	Abbott Nutrition Statement on Infant Formula Contamination in China
2008-08-07	Abbott Study Shows Investigational Heat-Stable Norvir® Tablet Provides Similar Drug Levels to Current Norvir Capsule
2008-08-07	Abbott Virology is proud to sponsor The Electronic Wake, a unique summer event that will leave no one untouched
2008-08-05	Abbott’s Kaletra® Tablet : Similar Clinical Results Across Race and Gender Lines
2008-07-29	Abbott Prepares to Submit Heat-Stable Norvir® Tablet for Registration by End of Year
2008-07-16	Abbott Reports Stronger-than-Expected Sales and Earnings Growth in Second Quarter and Raises Full-Year Outlook
2008-06-17	Abbott Nutrition Introduces New Web-Based Lifestyle Program for People with Diabetes
2008-05-21	Abbott Presents Long-term Data from Extension Study Showing Adult Crohn’s Patients Treated with HUMIRA® (Adalimumab) Maintained Remission
2008-01-24	HUMIRA^® is Now Approved in Canada for the Treatment of Moderate-to-Severe Plaque Psoriasis
2008-01-21	Health Canada approves HUMIRA^® (adalimumab) for treatment of Crohn's disease
2008-01-10	Abbott Named One the 50 Best Employers in Canada for Third Consecutive Year
2007-12-12	Synagis^® May Reduce Subsequent Recurrent Wheezing in Preterm Infants
2007-10-18	Abbott Scientists Create One Molecule With Two Antibody Functions
2007-09-27	Abbott's HUMIRA^® (adalimumab) Honored with Prestigious Galen Prize for Innovation in Patient Care
2007-09-17	Abbott Submits Canada, E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra^® and Aluvia^® (lopinavir/ritonavir) Tablet Suitable for Pediatric Use
2007-07-17	Abbott submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra®
2007-05-14	PUBLIC COMMUNICATION: Voluntary Recall of Depakene^® 500-mg
2007-05-11	HEALTHCARE PROFESSIONALS COMMUNICATION: Voluntary Recall of Depakene^® 500-mg
2007-04-30	Abbott Seeks Health Canada Approval of Humira® for Psoriasis
2007-03-23	Abbott launches new antibiotic for AECB
2007-02-13	Abbott Recognized as One of Canada's "50 Best Employers" by Hewitt Associates
2007-01-18	Abbott Diagnostics To Be Acquired By General Electric
2006-11-07	Humira approved in Canada for treatment of AS
2006-10-09	Abbott in The Montreal Gazette, October 9, 2006
2006-09-12	Abbott´s New Tablet Formulation of Kaletra Approved in Canada
2006-09-12	Now available : KALETRA Tablets!
2005-10-19	New Humira travel kit
2005-10-17	Humira now on eight government drug plans